![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management... Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain. Show more
LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (βAssertioβ or the βCompanyβ) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
LAKE FOREST, Ill., July 09, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (βAssertioβ or the βCompanyβ) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
LAKE FOREST, Ill., June 06, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (βAssertioβ or the βCompanyβ) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (βAssertioβ or the βCompanyβ) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
LAKE FOREST, Ill., May 29, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (βAssertioβ or the βCompanyβ) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.12 | -7.31707317073 | 1.64 | 1.7 | 1.34 | 880786 | 1.54322624 | CS |
4 | 0.28 | 22.5806451613 | 1.24 | 1.798 | 1.11 | 1251048 | 1.54913027 | CS |
12 | 0.51 | 50.495049505 | 1.01 | 1.798 | 0.9201 | 927590 | 1.28650956 | CS |
26 | 0.637 | 72.1404303511 | 0.883 | 1.798 | 0.7324 | 936750 | 1.0887137 | CS |
52 | -3.99 | -72.4137931034 | 5.51 | 5.78 | 0.7324 | 1413609 | 2.0331148 | CS |
156 | 0.27 | 21.6 | 1.25 | 8.01 | 0.7324 | 1293033 | 3.22095582 | CS |
260 | -1.5 | -49.6688741722 | 3.02 | 8.01 | 0.33 | 2347661 | 1.66302538 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions